Citi Pharma Limited (PSX:CPHL)
75.18
-0.39 (-0.52%)
At close: Sep 4, 2026
| Market Cap | 17.18B -22.5% |
| Revenue (ttm) | 13.84B +6.7% |
| Net Income | 1.10B +32.0% |
| EPS | 4.80 +31.9% |
| Shares Out | 228.46M |
| PE Ratio | 15.66 |
| Forward PE | n/a |
| Dividend | 3.50 (4.71%) |
| Ex-Dividend Date | Oct 17, 2025 |
| Volume | 244,352 |
| Open | 75.60 |
| Previous Close | 75.57 |
| Day's Range | 74.50 - 76.44 |
| 52-Week Range | 69.25 - 104.25 |
| Beta | 0.43 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Oct 2, 2026 |